Drew Spargo is currently an Advisor in Value, Evidence, and Outcomes at Eli Lilly and Company, where they have worked since 2022. Previously, they held the position of Consultant Scientist in Real World Evidence at Eli Lilly from 2020 to 2022 and managed Global Health Economics & Outcomes Research at Xcenda from 2018 to 2020. Drew earned a Master of Science in Pharmaceutical Outcomes and Policy from the University of Florida and an MBA from the Gatton College of Business and Economics, along with a Doctor of Pharmacy from the University of Kentucky. Their extensive experience includes roles as a Pharmacist Intern and pharmacy technician, contributing to health economics and outcomes research across various therapeutic areas.
This person is not in the org chart
This person is not in any teams
This person is not in any offices